Antimicrobial resistance and disease severity in hospitalized patients with acute exacerbation of bronchiectasis

Venkata Prathigna Kudipudi*, Deva Harshini Korlakunta, Kusuma Lalitha Madhuri Chintala, Swarnakumari Lalam, Mallika Mini

Department of pharmacy practice, Aditya college of pharmacy, Surampalem, Andhra Pradesh, India

Refer this article

Venkata Prathigna Kudipudi, Deva Harshini Korlakunta, Kusuma Lalitha Madhuri Chintala, Swarnakumari Lalam, Mallika Mini, 2026. Antimicrobial resistance and disease severity in hospitalized patients with acute exacerbation of bronchiectasis. Journal of medical pharmaceutical and allied sciences, V 15, I 3, Pages 23 – 28. Doi: https://doi.org/10.55522/jmpas.V15I3.7023.

ABSTRACT

Bronchiectasis is an increasingly recognized chronic lung disease marked by recurrent infections and airway damage. Antimicrobial resistance and the challenge of predicting disease progression necessitate combined microbiological and clinical evaluation. To investigate antimicrobial resistance profiles in acute exacerbations of bronchiectasis and explore the utility of the FACED score in predicting outcomes. A cross-sectional observational study was conducted among 59 patients (>20 years) admitted with acute exacerbations of bronchiectasis at a tertiary care hospital in East Godavari District (January 2024–March 2025).

Keywords:

Bronchiectasis, Antimicrobial resistance, Bacterial infections, Antibacterial agents, Hospitalization, Klebsiella pneumoniae.

Full Text Article